TYRA

Tyra Biosciences, Inc.

Name: Tyra Biosciences, Inc. insider trading (SEC Form 4) history
Creator: U.S. Securities and Exchange Commission

SEC CIK 1863127

$28.55 −3.1% · 90 days

90-day buys

0 open-market

90-day sells

$528.5K

1 open-market

Net insider flow

−$528.5K

Net selling

Filings shown

118

Most recent

At a glance

Over the last 90 days, insiders at TYRA have sold a net $528.5K of stock (0 open-market buys vs 1 sell).

Largest recent trade: More Robert J sold $5M of TYRA, trimming their stake 6%.

Most active filer: Bensen Daniel, with 55 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for TYRA, newest first

View on SEC EDGAR ↗

TYRA

Tyra Biosciences, Inc.

Sell Harris Todd · Director, Chief Executive Officer · Open-market sale · filed Jun 21, 2023 ΔOwn −3.0%

Harris Todd sold $867.3K of TYRA, trimming their stake 3%.

−$867.3K

50,838 sh @ $17

TYRA

Tyra Biosciences, Inc.

Sell Harris Todd · Director, Chief Executive Officer · Open-market sale · filed Jun 21, 2023

Harris Todd sold $11.1K of TYRA.

−$11.1K

600 sh @ $19

TYRA

Tyra Biosciences, Inc.

Sell Harris Todd · Director, Chief Executive Officer · Open-market sale · filed Jun 15, 2023 ΔOwn −0.7%

Harris Todd sold $206K of TYRA, trimming their stake 1%.

−$206K

12,773 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Bensen Daniel · Chief Operating Officer · Open-market sale · filed Jun 15, 2023 ΔOwn −2.3%

Bensen Daniel sold $203.3K of TYRA, trimming their stake 2%.

−$203.3K

12,592 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Bensen Daniel · Chief Operating Officer · Open-market sale · filed Jun 15, 2023

Bensen Daniel sold $2K of TYRA.

−$2K

120 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Harris Todd · Director, Chief Executive Officer · Open-market sale · filed Jun 15, 2023 ΔOwn −0.5%

Harris Todd sold $126.9K of TYRA.

−$126.9K

7,927 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Bensen Daniel · Chief Operating Officer · Open-market sale · filed Jun 15, 2023 ΔOwn −1.1%

Bensen Daniel sold $90.1K of TYRA, trimming their stake 1%.

−$90.1K

5,628 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Harris Todd · Director, Chief Executive Officer · Open-market sale · filed Apr 5, 2023 ΔOwn −0.1%

Harris Todd sold $32.3K of TYRA.

−$32.3K

2,000 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Bensen Daniel · Chief Operating Officer · Open-market sale · filed Apr 3, 2023 ΔOwn −0.4%

Bensen Daniel sold $32.3K of TYRA.

−$32.3K

2,000 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Bensen Daniel · Chief Operating Officer · Open-market sale · filed Apr 3, 2023 ΔOwn −0.1%

Bensen Daniel sold $6.4K of TYRA.

−$6.4K

400 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Harris Todd · Director, Chief Executive Officer · Open-market sale · filed Mar 31, 2023

Harris Todd sold $8K of TYRA.

−$8K

500 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Bensen Daniel · Chief Operating Officer · Open-market sale · filed Apr 3, 2023 ΔOwn −0.4%

Bensen Daniel sold $32K of TYRA.

−$32K

2,000 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Harris Todd · Director, Chief Executive Officer · Open-market sale · filed Mar 31, 2023 ΔOwn −0.1%

Harris Todd sold $38.6K of TYRA.

−$38.6K

2,407 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Harris Todd · Director, Chief Executive Officer · Open-market sale · filed Mar 31, 2023 ΔOwn −0.1%

Harris Todd sold $23K of TYRA.

−$23K

1,420 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Bensen Daniel · Chief Operating Officer · Open-market sale · filed Mar 29, 2023 ΔOwn −0.4%

Bensen Daniel sold $35.5K of TYRA.

−$35.5K

2,187 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Bensen Daniel · Chief Operating Officer · Open-market sale · filed Mar 29, 2023 ΔOwn −0.6%

Bensen Daniel sold $53.5K of TYRA, trimming their stake 1%.

−$53.5K

3,346 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Harris Todd · Director, Chief Executive Officer · Open-market sale · filed Mar 28, 2023 ΔOwn −0.2%

Harris Todd sold $44.5K of TYRA.

−$44.5K

2,779 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Bensen Daniel · Chief Operating Officer · Open-market sale · filed Mar 29, 2023 ΔOwn −1.5%

Bensen Daniel sold $128.8K of TYRA, trimming their stake 2%.

−$128.8K

8,048 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Harris Todd · Director, Chief Executive Officer · Open-market sale · filed Mar 28, 2023 ΔOwn −0.2%

Harris Todd sold $47.4K of TYRA.

−$47.4K

2,963 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Harris Todd · Director, Chief Executive Officer · Open-market sale · filed Mar 28, 2023

Harris Todd sold $2.7K of TYRA.

−$2.7K

170 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Harris Todd · Director, Chief Executive Officer · Open-market sale · filed Mar 23, 2023 ΔOwn −0.2%

Harris Todd sold $44.8K of TYRA.

−$44.8K

2,800 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Bensen Daniel · Chief Operating Officer · Open-market sale · filed Mar 23, 2023 ΔOwn −0.9%

Bensen Daniel sold $77.2K of TYRA, trimming their stake 1%.

−$77.2K

4,827 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Harris Todd · Director, Chief Executive Officer · Open-market sale · filed Mar 23, 2023 ΔOwn −0.2%

Harris Todd sold $64.7K of TYRA.

−$64.7K

4,043 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Bensen Daniel · Chief Operating Officer · Open-market sale · filed Mar 23, 2023 ΔOwn −0.7%

Bensen Daniel sold $60.8K of TYRA, trimming their stake 1%.

−$60.8K

3,800 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Harris Todd · Director, Chief Executive Officer · Open-market sale · filed Mar 23, 2023 ΔOwn −0.7%

Harris Todd sold $198.3K of TYRA, trimming their stake 1%.

−$198.3K

12,393 sh @ $16

TYRA

Tyra Biosciences, Inc.

Sell Bensen Daniel · Chief Operating Officer · Open-market sale · filed Mar 23, 2023 ΔOwn −2.6%

Bensen Daniel sold $225.6K of TYRA, trimming their stake 3%.

−$225.6K

14,100 sh @ $16

TYRA

Tyra Biosciences, Inc.

Buy MORE ROBERT J · Director · Open-market purchase · filed Sep 17, 2021 ΔOwn +4.0%

More Robert J, TYRA's Director, spent $2.5M of their own money on 156,250 shares at $16, growing their stake 4%.

+$2.5M

156,250 sh @ $16

TYRA

Tyra Biosciences, Inc.

Buy Alta Partners NextGen Fund II Management, LLC · 10% Owner · Open-market purchase · filed Sep 17, 2021 ΔOwn +4.0%

Alta Partners Nextgen Fund Ii Management, Llc, TYRA's 10% owner, spent $2.5M of their own money on 156,250 shares at $16, growing their stake 4%.

+$2.5M

156,250 sh @ $16

About TYRA insider activity

This page tracks every recent Form 4 filed for Tyra Biosciences, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is TYRA insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Tyra Biosciences, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.